Barclays PLC Galmed Pharmaceuticals Ltd. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$7.27 - $9.07 $2,013 - $2,512	-277 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.59 - $14.47 $1,825 - $4,008	277 New	277 $2,000
Q3 2018 Nov 14, 2018	SELL	$10.55 - $15.28 $15,825 - $22,920	-1,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.04 - $17.96 $7,560 - $26,940	1,500 New	1,500 $18,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $69M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.